Good outcomes for HCV-negative recipients of HCV kidneys

August 7, 2018

(HealthDay)—Hepatitis C virus (HCV)-negative recipients of HCV-infected kidneys experience HCV cure and good quality of life, according to research published online Aug. 7 in the Annals of Internal Medicine.

Peter P. Reese, M.D., from the University of Pennsylvania in Philadelphia, and colleagues describe 12-month HCV treatment outcomes for 10 recipients in two small trials including the Transplanting Hepatitis C kidneys into Negative Kidney Recipients (THINKER-1) trial. Six-month data were included for 10 additional recipients. The recipients received kidneys infected with HCV genotype 1 and on post-transplant day three they received elbasvir-grazoprevir.

The researchers found that all participants achieved HCV cure. Hepatic and renal complications were managed successfully or were transient. At four weeks, the mean RAND-36 Physical Component Summary (PCS) and Mental Component Summary (MCS) quality-of-life scores decreased, followed by an increase in PCS scores above pretransplant values, while MCS scores returned to baseline. The estimated glomerular filtration rates were similar for THINKER participants and matched recipients of HCV-negative kidneys at six and 12 months (median, 67.5 versus 66.2 mL/min/1.73 m² and 72.8 versus 67.2 mL/min/1.73 m², respectively).

"In summary, this trial provides reassuring (albeit preliminary) evidence that kidneys from HCV-infected donors may be safely transplanted into HCV-negative recipients," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Merck, which funded the study and provided elbasvir-grazoprevir.

Explore further: One year posttransplant, recipients of hepatitis C kidneys disease-free

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

One year posttransplant, recipients of hepatitis C kidneys disease-free

March 5, 2018
In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of ...

Patients who accepted infected kidneys cured of hepatitis C

August 6, 2018
Some patients in desperate need of a kidney transplant participated in a bold experiment where they received organs infected with hepatitis C. The gamble paid off.

Graft survival similar for kidneys from octogenarians

August 15, 2017
(HealthDay)—Graft survival is similar for recipients of kidneys from >80-year-old donors and donors aged ≤60 years, according to a study published online Aug. 9 in the American Journal of Transplantation.

Transplanting HCV+ kidneys into HCV- recipients feasible

May 14, 2017
(HealthDay)—In a research letter published online April 30 in the New England Journal of Medicine, Philadelphia doctors write that they have cleared hepatitis C infections in 10 patients who received kidneys from deceased ...

Blood samples used to investigate adaptive repair mechanisms of transplanted kidneys

July 31, 2018
Researchers at Wake Forest Baptist Medical Center have shown that gene expression analysis of blood samples taken from the recipients of transplanted kidneys can be used to better understand the mechanisms that promote repair ...

Researchers urge use of hepatitis C-positive kidneys as one solution to kidney shortage

July 23, 2015
The average wait time for a kidney transplant is five years and there are more than 100,000 people on the waiting list. However, there are thousands of viable hepatitis C-positive kidneys that are discarded each year solely ...

Recommended for you

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.